SEC Form 4 · accession 0001185185-15-003251
U.S. Stem Cell, Inc. · USRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mike Tomas
Officer — CEO & President · Director
Period of report
Dec 2, 2015
Accepted (ET)
Dec 7, 2015 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 2, 2015 | C | 1,100 | — | A | 7,679 | D | |
| Common StockF2 | Dec 3, 2015 | C | 600 | — | A | 8,279 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1$1.5499 to $2.098
- F2$1.983 to $2.00